Sectors

BIO
Bio-Rad Laboratories, Inc.
376.41
240 x 306.02
120 x 376.12
bid
ask
-
6.00
1.57%
180 @ 07:30 PM
376.41 -0.00 (0.00%)
Ytd24.23%
1y31.39%
374.81
day range
382.99
241.71
52 week range
390.34
Open383.05Prev Close382.41Low374.81High382.99Mkt Cap10.06B
Vol324.35KAvg Vol293.15KEPS8.22P/E45.79Forward P/E37.47
Beta1.07Short Ratio4.23Inst. Own91.25%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning10-2950-d Avg349.16200-d Avg304.321yr Est329.00
Earning
DateForEstimateReportedSurprisesurprise %
2026-10-292026-092.23N/AN/AN/A
2026-08-042026-061.752.620.8749.71%
2026-04-302026-031.971.89-0.08-4.06%
2026-02-122025-122.572.51-0.06-2.33%
2025-10-292025-092.32.26-0.04-1.74%
2025-07-312025-061.932.610.6835.23%
Upgrade / Downgrade
DateFirmActionFromTo
2026-08-07RBC CapitalUpgradeOutperformOutperform
2026-08-05CitigroupUpgradeNeutralNeutral
2026-08-05RBC CapitalUpgradeOutperformOutperform
2026-08-05Wells FargoUpgradeEqual-WeightEqual-Weight
2026-05-01Wells FargoUpgradeEqual-WeightEqual-Weight
2026-04-07CitigroupDowngradeBuyNeutral
Profile
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Insider Holder
DateNameRelationQuantityDescription
2026-09-03ALLISON SCHWARTZDirector1.73KConversion of Exercise of derivative security
2026-09-03BARRY JAMESOfficer2.02KConversion of Exercise of derivative security
2025-09-04COREY COLLEENOfficer19.55KConversion of Exercise of derivative security
2025-03-13CROWLEY MICHAEL WOfficer8.17KConversion of Exercise of derivative security
2026-09-03DIVINCENZO JONATHAN PPresident1.96KConversion of Exercise of derivative security
2026-09-03ENGELHARDT EVA ANETTEOfficer1.83KConversion of Exercise of derivative security
Institution Ownership
Report DateOrganizationPositionValuePercentage
2026-06-29First Eagle Investment Management, LLC2.61M979.26M12.02%
2026-06-29Blackrock Inc.1.70M638.36M7.84%
2026-06-29Dimensional Fund Advisors LP944.55K354.90M4.36%
2026-06-29Vanguard Capital Management LLC826.97K310.73M3.81%
2026-06-29Vanguard Portfolio Management LLC816.20K306.68M3.77%
2026-06-29Ariel Investments, LLC816.75K306.89M3.77%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-04-29First Eagle Funds-First Eagle Global Fund1.88M705.92M8.67%
2026-06-29SmallCap World Fund Inc881.72K331.30M4.07%
2026-07-30iShares Trust-iShares Core S&P Mid-Cap ETF618.66K232.45M2.85%
2026-06-29VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund584.78K219.73M2.70%
2026-06-29VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund423.19K159.01M1.95%
2026-06-29Ariel Investment Trust-Ariel Fund349.27K131.23M1.61%
Split
SplitDate
2 : 12002-03-08
3 : 21996-06-03
3 : 21986-06-11
1 : 11986-06-10
3 : 21985-08-01
1 : 11985-07-31